| Literature DB >> 25251192 |
Shuyu Sun1, Kang Zheng2, Hongyan Zhao3, Cheng Lu4, Biao Liu5, Changyuan Yu6, Ge Zhang7, Zhaoxiang Bian8, Aiping Lu9, Xiaojuan He10.
Abstract
Astragalus polysaccharides (APS) possess multiple immunomodulatory activities. Due to its high molecular weight, orally administration of APS is not easily absorbed into the blood stream, and how APS exerts its capacity in vivo is still not well elucidated. We assume that enteric mucosal immune response might trigger the immune regulation of APS, and our previous studies demonstrated that APS had regulatory activity on intraepithelial lymphocytes (IELs). Therefore, this study aimed to investigate the functions of APS on intestinal intraepithelial γδT cells, a major subset in IELs and an essential component of maintaining homeostasis and immune regulation in enteric mucosa. Results showed that APS could promote proliferation and function of intestinal intraepithelial γδT cells in vitro, the IFN-γ, FasL and GrB mRNA levels in γδT cells were all significantly increased. Moreover, APS also improved the activity of intestinal intraepithelial γδT cells in vivo, as cytokines production and cytotoxicity of γδT cells were all remarkably improved in tumor-bearing mice treated with APS. In addition, the levels of TNF-α and IFN-γ were significantly increased, whereas the levels of IL-10 and TGF-β were significantly decreased in tumor-bearing mice treated with APS. In conclusion, this study demonstrated that APS could improve proliferation and function of intestinal intraepithelial γδT cells, which might an important pathway for immunomodulation of APS in cancer therapy.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25251192 PMCID: PMC6271644 DOI: 10.3390/molecules190915224
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1APS stimulates mice intestinal intraepithelial γδT cells in vitro. (A) A representative flow cytometric results of purified intestinal intraepithelial γδT cells. (B) CCK-8 assay to measure the proliferation of γδT cells treated with different concentrations of APS. (C,D) ELISA assay to detect the concentration of IFN-γ and TNF-α in cultivated supernatants of γδT cells treated by APS. * P < 0.05, vs. control; ** P < 0.01, vs. control. (E,F) Real-time PCR assay to detect the mRNA levels of FasL and GrB in γδT cells treated by APS. ** P < 0.01, vs. control.
Figure 2APS inhibits tumor growth in tumor bearing mice. The repression rate (%) = (mean weight of tumor of model control group − mean weight of tumor of drug-treatment group)/mean weight of tumor of model control group × 100%.
Figure 3APS stimulates intestinal intraepithelial γδT cells from tumor-bearing mice. Real-time PCR assay to detect the mRNA levels of IFN-γ, TNF-α, FasL, and GrB in intestinal intraepithelial γδT cells separated from tumor-bearing mice. * P < 0.05, vs. model group; ** P < 0.01, vs. model group.
Figure 4APS regulates Th1/Th2 cytokines balance in tumor-bearing mice. Expression of cytokines TNF-α, IFN-γ, IL-10 and TGF-β in serum were determined using ELISA. ## P < 0.05, vs. normal group; * P < 0.05, vs. model group; ** P < 0.01, vs. model group.